FDA Calls For More Warnings On Breast Implant Labeling
Executive Summary
Suggested revisions to breast implant labeling guidance from the US FDA include a boxed warning, patient decision checklist, and additional information for patients about device ingredients. The changes follow growing concerns over the safety of certain implants.